PAA 2.63% 19.5¢ pharmaust limited

GREAT NEWS, page-51

  1. 2,951 Posts.
    lightbulb Created with Sketch. 1085
    Brilliant and very interesting article indeed and does point to the use of MPL in the treatment of MND. If this was actually the case then PAA and all SH are missing out on exciting news including a formidable boost to the science of MPL and PAAs share price.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.